Ewing's sarcoma is associated with a fusion between the EWS and FLI1 genes, forming an EWS/FLI fusion protein. We developed a system for the identification of cooperative mutations in this tumor through expression of EWS/FLI in primary human fibroblasts. Gene expression profiling demonstrated that this system recapitulates many features of Ewing's sarcoma. EWS/FLI-expressing cells underwent growth arrest, suggesting that growth arrest-abrogating collaborative mutations may be required for tumorigenesis. Expression profiling identified transcriptional upregulation of p53, and the growth arrest was rescued by inhibition of p53. These data support a role for p53 as a tumor suppressor in Ewing's sarcoma and demonstrate the use of transcriptional profiling of model systems in the identification of cooperating mutations in human cancer.
Introduction
human Ewing's sarcomas, suggesting that the morphology of the tumor may be governed by the EWS/FLI oncogene itself, The study of solid tumor formation in pediatrics has made great rather than by the tumor's cell of origin (Teitell et al., 1999) . strides in recent years by the identification of recurrent chromoImportantly, other cell types (e.g., Rat-1 fibroblasts, Ncm1, CTR, somal alterations involved in these tumors (reviewed in Sorenand the NIH 3T3-derived line YAL-7) are not transformable by sen and Triche, 1996). Ewing's sarcoma serves as a paradigm EWS/FLI, suggesting that the fusion protein may not be suffifor this tumor class, since virtually all Ewing's sarcomas contain cient for transformation (Arvand et al., 1998 , and references one of a small group of chromosomal translocations (reviewed therein). The full spectrum of EWS/FLI-collaborating mutations, in Kim and Pelletier, 1999; Kovar, 1998) . The most common however, is not known, and the requirements for transformation translocation is the t(11;22)(q24;q12), which results in a fusion by EWS/FLI in primary cells is poorly understood. protein containing the amino terminus of the EWS protein joined
To address the functional consequences of EWS/FLI in prito the carboxyl terminus of the FLI1 protein, an ETS transcription mary cells, we report here the establishment of telomerasefactor (Dellatre et al., 1992) . It is believed that the consequence immortalized human primary fibroblasts conditionally expressof this fusion is to replace the weak transcriptional activation ing the fusion protein. These cells underwent EWS/FLI-induced domain of FLI1 with a strong transcriptional activation domain growth arrest, consistent with the notion that tumorigenesis from EWS (Lessnick et al., 1995; May et al., 1993b) . The other requires the acquisition of additional mutations that abrogate Ewing's sarcoma-associated translocations fuse the amino terthis growth arrest response. To work toward the elucidation minus of EWS to the DNA binding domain of other ETS family of this multistep oncogenic process, transcriptional profiling transcription factors.
coupled with functional validation studies were performed. Although the cell of origin of Ewing's sarcoma is not known, These experiments indicated that this growth arrest is p53 dethe transforming potential of EWS/FLI has been demonstrated pendent, supporting the importance of p53 loss of function in in NIH 3T3 fibroblasts, where it induces colony formation in soft the pathogenesis of Ewing's sarcoma and demonstrating the agar and forms tumors when injected in immunodeficient mice feasibility of this experimental approach to finding cooperative (May et al., 1993a; Teitell et al., 1999) . These tumors share the "small round blue cell" and neural differentiation properties of mutations in cancer.
S I G N I F I C A N C E
Cancer arises as a consequence of multiple cooperating genetic events. The unique character and early age of onset of pediatric tumors suggests that there may be qualitative and/or quantitative differences in the alterations required as compared to adult tumors, but this has not been systematically evaluated. Such an evaluation has been hampered by the difficulty in identification of cooperative mutations involved in these tumors. We developed a system to identify cooperative mutations in the pediatric tumor Ewing's sarcoma. We describe a generalizable approach to the validation of this experimental system using microarray-based transcriptional profiling of primary patient samples. The utility of this approach is demonstrated by the identification and functional validation of p53 as a tumor suppressor in Ewing's sarcoma. Although the total number of cells is decreased in the induced tet-EF sample (Ϫdox) as compared to the uninduced tet-EF cell sample (ϩdox), the absolute number of cells staining positively for SA-␤-gal is identical between the two. A senescent positive control (tet-ctrl cells expressing SV40 small T antigen) is shown for comparison. E: The growth arrest of tet-EF cells is reversible, as demonstrated by resumption of growth when EWS/FLI expression was inhibited by the readdition of doxycycline to the growth media. The standard deviations from triplicate samples are represented by error bars.
Results response, such as that seen with c-myc expression in nontransformed fibroblasts (reviewed in Prendergast, 1999) . In situ staining with FITC-VAD-fmk, gel electrophoresis to detect genomic Growth phenotype of inducible EWS/FLI To study the biological effects of EWS/FLI in primary human DNA laddering, DAPI staining of nuclei to detect characteristic nuclear condensation, and annexin V staining, a hallmark of cells, human neonatal foreskin fibroblasts were infected with a retrovirus harboring the human telomerase (hTERT) cDNA to apoptosis, similarly failed to demonstrate an apoptotic response to EWS/FLI expression (data not shown). Additionally, in conprovide for an extended life span without karyotypic abnormalities. These cells were then engineered to express EWS/FLI trast to the effects of RAS expression in primary cells (Serrano et al., 1997) , EWS/FLI did not induce a senescent phenotype, under the control of a tetracycline-repressible element and were designated tet-EF cells ( Figure 1A) . A control cell line (tet-ctrl as demonstrated by the absence of the typical morphologic changes of cellular senescence and the absence of senescencecells) lacking the EWS/FLI cDNA was similarly generated.
Growth curves were generated using tet-EF and tet-ctrl cells associated ␤-galactosidase activity ( Figure 1D ). Furthermore, the EWS/FLI-induced growth arrest was completely reversed following the withdrawal of doxycycline ( Figure 1B ). Control cells grew similarly in the presence or absence of doxycycline. In by the readdition of doxycycline, thereby repressing EWS/FLI expression ( Figure 1E ). (Figure 2A) . FLI expression. Given this comparable level of expression, it is unlikely that the Among EWS/FLI upregulated genes were frizzled-1 (FZD1), growth arrest observed in EWS/FLI-expressing tet-EF cells is FRAT2 (a GSK binding protein), and MYC, suggesting that modsimply a result of overexpression of the fusion protein.
ulation of the WNT signaling pathway may be occurring in these Tet-EF cells induced to express EWS/FLI were next analyzed cells, and consistent with the observation of elevated levels of on DNA microarrays containing probes for approximately c-MYC in Ewing's sarcoma (McKeon et al., 1988) . Upregulation 12,600 named genes and expressed-sequence tags (see of the PDGF-receptor-␤ (PDGFRB), the PI-3-kinase p85 subunit Supplementary Information at http://www.genome.wi.mit.edu/ (PIK3R1), and multiple MAP-kinase pathway genes (such as cancer/Ewings). Among the genes induced by EWS/FLI in these MAPK10, MAP2K5, and MAPKAPK2) suggests that EWS/FLI experiments was MIC2, a marker of Ewing's sarcoma used in may modulate multiple points in receptor tyrosine-kinase pathroutine clinical practice ( Figure 2B ; Ambros et al., 1991; Fellinger ways. Interestingly, induction of VEGF expression by EWS/FLI et al., 1991) . This result supports the validity of the cell culture suggests a possible mechanism for the extensive tumor angiosystem for the study of EWS/FLI. genesis observed in Ewing's sarcoma. An additional group of To further explore the validity of this model system, we EWS/FLI-induced genes include p53 (TP53), FAS/APO compared the list of EWS/FLI-induced genes to the gene ex-(TNFRSF6), CDKN1C, TGFB1, and TIMP3-all of which are aspression profiles of Ewing's sarcoma patient samples. The sociated with tumor growth inhibition. We hypothesized that 12,600 gene oligonucleotide microarray data generated herein these genes represent cell-autonomous tumor-suppressive rewere compared to the 2308 gene cDNA microarray data of Khan sponses to oncogenic stress. One implication of this hypothesis et al., which represent 63 small round blue cell tumors and cell is that Ewing's sarcoma tumor cells have bypassed these cellulines, including 23 Ewing's sarcomas, 8 Burkitt's lymphomas, lar responses to allow for unrestricted cell growth. As described 12 neuroblastomas, and 20 rhabdomyosarcomas (Khan et al., below, the plausibility of this hypothesis was functionally vali-2001). Permutation testing of the oligonucleotide array data dated for one of these genes-p53. revealed that 117 probes were reproducibly induced by EWS/ FLI in tet-EF cells (p Ͻ 0.01; Figure 2C ). Analysis of the patient EWS/FLI induction of p53 samples identified 686 probes that were statistically significant p53 represents an attractive candidate to explain EWS/FLImarkers of Ewing's sarcoma (p Ͻ 0.01; Figure 2C ). Strikingly, mediated growth arrest, since p53 transcript levels were more 54 (46.2%) of the 117 genes that were induced by the EWS/ highly correlated with EWS/FLI expression than any of the other FLI fusion in tet-EF cells were also Ewing's-specific markers, 12,600 genes on the array, and increases in p53 function are far beyond what would have been expected by chance alone thought to be central to the growth arrest and increased cell (p Ͻ 0.0001; Figure 2D ). We similarly identified genes that were death observed in primary cells expressing oncogenes (Serrano specific to Burkitt's lymphoma, neuroblastoma, and rhabdoet al., 1997; Zindy et al., 1998) . Quantitative, real-time PCR myosarcoma, and compared these to the EWS/FLI-induced experiments showed induction of p53 mRNA levels that were genes in tet-EF cells (Figures 2C and 2D) . No significant molecuconsistent with the microarray findings ( Figure 3B ). Western blot lar similarity between the tet-EF cells and these other tumor analysis further demonstrated significant increases in p53 levels types was observed ( Figure 2D ). These results demonstrate that following EWS/FLI induction ( Figure 4A ). Similar increases in tet-EF cells have molecular features that are similar to Ewing's the p53 target p21 support the notion that the increase in p53 sarcoma, and thus they confirm the suitability of tet-EF cells as levels was functionally significant (see Figure 4C ). a model of Ewing's sarcoma.
Oncogene expression in primary murine fibroblasts often activate the p53 tumor suppressor via increases in the p19ARF Molecular consequence of EWS/FLI expression protein (p14ARF in human cells), which results in increased We next explored the mechanism by which EWS/FLI induces stability of p53 and accumulation of active protein (Bates et al., growth arrest, reasoning that genes involved in that process 1998; Damalas et al., 2001; de Stanchina et al., 1998 ; Palmero would be candidates for collaborating mutations in Ewing 's tuet al., 1998; Pomerantz et al., 1998; Zhang et al., 1998 ; Zindy et morigenesis. For this purpose, we turned again to the gene al., 1998). Posttranslational regulation of p53 levels are similarly expression consequences of EWS/FLI induction in tet-EF cells.
observed in MDM2-overexpressing cells (Haupt et al., 1997 ; EWS/FLI-regulated genes were clustered using self-organizing Kubbutat et al., 1997) . The observed increases in p53 mRNA maps (SOM) in order to capture the predominant patterns of levels in tet-EF cells, however, raised the possibility that the gene expression ( Figure 3A ; Tamayo et al., 1999) . The data regulation of p53 in this system may occur transcriptionally. In could be divided into three major groups: those that were downsupport of this, we observed no increase in p14ARF protein regulated in response to EWS/FLI (cluster 0; 347 genes), those levels in response to EWS/FLI expression and minimal change that were upregulated (cluster 2; 214 genes), and those that in MDM2 protein levels ( Figure 4A ). Quantitative, real-time PCR had more variable expression patterns (cluster 1; 134 genes).
experiments demonstrated no increase in p14ARF mRNA levels A complete list of these genes can be found in Supplemental and, in fact, demonstrated 3-fold decrease in mRNA levels, in good agreement with the Western blot data (data not shown). Information at http://www.genome.wi.mit.edu/cancer/Ewings. A: Western blot analysis using an anti-FLI-1 antibody demonstrates that the level of EWS/FLI expressed in the absence of doxycycline is similar to the levels of EWS/FLI protein expressed by the Ewing's sarcoma cell lines A673, SK-N-MC, RD-ES-1, and EWS-502. Tubulin is shown as a loading control. B: Microarray-detected MIC2 mRNA expression levels increase following EWS/FLI expression. C: The oligonucleotide microarray data for tet-EF cells expressing EWS/FLI were compared to the publicly-available cDNA microarray expression data for pediatric small round cell tumors (SRCT) (Khan et al., 2001) , including Ewing's sarcoma, Burkitt's lymphoma (BL), neuroblastoma (NBL), and rhabdomyosarcoma (RMS). Oligonucleotide probes and cDNAs were first mapped to their Unigene clusters, and clusters that were present on both microarray platforms were identified. Data from the common clusters were used for the subsequent analysis. The different numbers of probes/cDNAs obtained for each data set is a result of different amounts of redundancy present on each platform. K-nearest neighbor (Knn) analysis and permutation testing was used to identify those genes that increase following EWS/FLI expression in tet-EF cells (left; n ϭ 117 at 99% significance level). A representative experiment is shown. Each column represents the day following induction of EWS/FLI. Each row represents a different gene. The same method was used to identify marker genes that are more highly expressed in each SRCT type than expected by chance alone (right; the top 50 genes are shown for each tumor type). For both panels, expression levels are normalized such that the mean is 0 and the standard deviation is 1. Expression levels above the mean are red, and those below the mean are blue. D: EWS/ FLI-regulated genes are more overlapping with Ewing's sarcoma markers than would be expected by chance alone (p Ͻ 0.0001). For each tumor type shown, the number of probes that pass permutation testing at the 99% significance level is shown. Chi-square analysis was used to generate the p values.
Finally, pulse-chase experiments demonstrated that p53 halfvated in response to EWS/FLI expression. Thus, EWS/FLI expression results in increased p53 levels because of transcriplife was not prolonged following EWS/FLI induction ( Figure 4B ). Importantly, introduction of p14ARF or p53 expression by rettional upregulation, rather than posttranslational mechanisms. roviral transduction led to the anticipated increases in both MDM2 and p53 levels ( Figure 4A ; Stott et al., 1998) 
. Taken
Growth arrest is p53 dependent We next determined whether p53 induction was critical for the together, these results demonstrate that tet-EF cells carry a functional ARF-MDM2-p53 axis, but this pathway is not actiobserved growth arrest phenotype following EWS/FLI induction.
Figure 3. EWS/FLI upregulates p53 transcription
A: Self-organized map analysis of tet-EF cells expressing EWS/FLI. The tet-EF cell microarray data was initially filtered to limit the data set to those genes that demonstrated at least 2.5-fold changes in two or more time points as compared to day 0. Genes were then grouped into three clusters (a 3 ϫ 1 SOM). The mean expression level of each clustered time point is represented in blue, and the standard deviations are in red. Independent dupli- Figure 4 . EWS/FLI increases p53 protein levels cate EWS/FLI inductions in tet-EF cells are represented, and the day of A: Western blot analysis of the p53 pathway in tet-EF cells following 3 days induction of each point is indicated. Cluster 0 (c0) represents downreguof induced EWS/FLI expression. EWS/FLI expression results in increased p53 lated genes, cluster 2 (c2) represents upregulated genes, and cluster 1 (c1) protein levels without increased p14ARF levels or significant alterations in represents genes with intermediate/indeterminate patterns. B: Quantitative MDM2 levels. Infection of tet-EF cells with a p14ARF retrovirus demonstrates real-time PCR (qRT-PCR) of an independent sample of tet-EF cells expressing that p14ARF is able to mediate increased p53 levels. Increased MDM2 levels EWS/FLI demonstrates similar increase in p53 mRNA as compared to the are observed following infection of either p14ARF or p53 retroviruses, as has microarray analysis. The p53 mRNA expression level from the microarray is been previously reported , and references therein). Tubulin plotted on the left, and the levels as determined by qRT-PCR is shown on is shown as a loading control. B: Pulse-chase analysis of p53 protein stability the right. The microarray data represents the mean of both runs with the in the presence of EWS/FLI expression (open circles, without doxycycline) standard deviations indicated. The qRT-PCR analysis was performed on a or in the absence of EWS/FLI expression (closed circles, with doxycycline). single independent sample pair.
Relative p53 quantities (as determined using a phosphor imager) are shown plotted against time (on a logarithmic scale an inhibitor of p53 (Vousden, 1993) . Polyclonal populations of tet-EF cells stably expressing E6 (tet-EF/E6 cells) were generated by retroviral gene transfer. Control cells lacking E6 (tetMultistep process of transformation EF/zeo) were similarly derived.
We next asked whether inhibition of p53 was sufficient for EWS/ E6 expression in tet-EF cells led to expected diminution of FLI-mediated transformation. Tet-EF/E6 cells were plated in soft basal p53 protein levels and was able to completely inhibit agar in the presence and absence of doxycycline. No colonies increased p53 levels seen with EWS/FLI induction ( Figure 4C ).
formed when tet-EF/E6 cells were induced to express EWS/FLI Additionally, increases in p21 were also inhibited by the presprotein ( Figure 5B ). Importantly, these cells do become transence of the E6 protein ( Figure 4C ). Importantly, EWS/FLI expresformed through coexpression of HPV E6 and E7, SV40 small T sion levels were similar in the two cell types ( Figure 4C) .
antigen, and RAS V12 ( Figure 5B ; Hahn et al., 2002) . Interestingly, The growth characteristics of tet-EF/E6 cells are shown (Fig- the colony-forming potential of these cells is inhibited by expresure 5A). Whereas tet-EF/zeo cells undergo growth arrest in resion of EWS/FLI, suggesting that additional tumor-suppressive sponse to EWS/FLI induction, this growth arrest was completely pathways may be operative in these cells. To examine this possiabrogated by E6 expression. A dominant-negative allele of p53 bility, 3T5 growth assays were performed with tet-EF/E6 cells. demonstrated a similar bypass in the growth arrest response Whereas E6 blocked an early, p53-dependent growth arrest, to EWS/FLI (see below). These experiments indicate that p53 subsequent p53-independent growth inhibition was then encountered ( Figure 5C ). A dominant-negative allele of p53, is a critical mediator of EWS/FLI growth arrest. p53DD (Shaulian et al., 1992) , similarly abrogated the growth Activation of tumor suppressor pathways by oncogenic stress is an emerging theme. RAS, MYC, E1A, E2F1, and arrest phenotype, suggesting that the effects observed with HPV E6 are a result of its p53-inhibitory functions, rather than its ␤-catenin (CTNNB1) all induce p53-dependent growth-inhibitory responses when expressed in primary murine cells (Bates p53-independent activities. Taken together, these data suggest that the pathogenesis of Ewing's sarcoma requires not only Damalas et al., 2001; de Stanchina et al., 1998; Palmero et al., 1998; Zindy et al., 1998) . In each of these inabrogation of the p53 pathway, but also requires mutations in genes leading to the abrogation of an additional, as yet uncharstances, upregulation of p53 protein levels is thought to be mediated by the ARF-MDM2-p53 axis. Indeed, expression of acterized growth-suppressive pathway.
EWS/FLI in primary murine fibroblasts results in a growth arrest with apoptosis that can be circumvented by loss of either Discussion p19ARF or p53 (Deneen and Denny, 2001 ). Importantly, we did not observe activation of the ARF-MDM2 pathway in primary We have demonstrated the potential for deciphering the human fibroblasts, suggesting that regulation of the p53 tumor multistep pathogenesis of Ewing's sarcoma by integrating transuppressor may be different in different organisms. Consistent scriptional profiling data from model systems and patient tumor samples with functional assays in model systems. We identified with this notion, recent work from Sedivy and coworkers has demonstrated that p53 induction by RAS in primary human p53 as a potential tumor suppressor in Ewing's sarcoma through this method. A role for p53 alterations in Ewing's sarcoma is fibroblasts also occurs in an ARF-independent fashion (Wei et al., 2001 ). Thus, it would appear that regulation of p53 levels supported by the clinical literature, and thus lends validity to this approach. Mutations in p53 have been detected in 5%-20% by oncogenic stress in primary human cells utilizes different upstream components than those used in murine cells. In the of Ewing's sarcoma tumor samples (Kovar et al., 1993; PatinoGarcia and Sierrasesumaga, 1997) . Amplification of MDM2 and case of EWS/FLI, transcriptional upregulation of p53 seems to be the predominant mode of regulation. Additional work will be deletions of the CDKN2A locus (encoding overlapping INK4A and ARF transcripts) have also been described in Ewing's sarrequired to determine whether this finding is specific for EWS/ FLI, or whether it is a more generalized phenomenon. As many coma (e.g., Kovar et al., 1997; Ladanyi et al., 1995) . Thus, alterations in the p53 pathway may be relatively frequent in this cases of Ewing's sarcoma have no evidence of mutation of the p53 pathway, abrogation of the transcriptional induction of p53 tumor. report, may provide evidence for functional roles of these in (Serrano et al., 1997 as detailed in the supplemental section. K-nearest neighbor (Knn) analysis and SOMs were performed using our GeneCluster software package availExperimental procedures able at http://www-genome.wi.mit.edu/cancer/software/software (Golub et al., 1999; Tamayo et al., 1999) . Complete data sets, in-depth description Constructs and retroviruses of the analysis, and supplemental materials are available at http://www. The human telomerase (hTERT) cDNA was cloned into the pWZL-blast⑀ genome.wi.mit.edu/cancer/Ewings. vector, which directs blasticidin resistance. HPV16 E6 and E6E7 cDNAs were PCR amplified from an HPV16 genomic plasmid and cloned into pWZLReal-time quantitative PCR zeo⑀ vector. FLAG-epitope-tagged EWS/FLI was subcloned into the pREVThree days after EWS/FLI induction in tet-EF cells, total cellular RNA was TRE vector (Clontech). The cDNAs for p14ARF and wild-type p53 were prepared and was treated with RNase-free DNase I (Promega). Reactions subcloned into the MSCV-puro vector (Clontech) for retroviral production were prepared using TaqMan One-Step RT-PCR reagents from Applied and into the pBluescript II KSϩ vector (Stratagene) for in vitro transcription Biosystems. One-step RT-PCR consisted of an initial incubation at 48ЊC for reactions. The cDNA for p53DD was subcloned into the pBabe-puro vector 30 min, followed by a denaturation step at 95ЊC for 10 min and amplification (Morgenstern and Land, 1990) .
for 40 cycles of 15 s at 95ЊC and 1 min at 60ЊC. For each case, 200 ng of total Vesicular stomatitis virus-G glycoprotein pseudotyped retroviruses were RNA was analyzed. Each experiment included three nontemplate controls to prepared by transient cotransfection of retroviral vectors with packaging detect any template contamination; a control lacking reverse transcriptase plasmids in either 293-EBNA (Invitrogen) or 293T cells. Infection of target was included for each sample to detect any residual genomic DNA. Standard cells was carried out in the presence of 8 g/ml polybrene. curves were constructed by serial 10-fold dilutions from 10 7 to 10 3 copies of in vitro transcribed RNA of each gene to be quantified. The reproducibility Cell culture of the quantitative measurements was evaluated by conducting triplicate Primary fibroblasts were prepared from discarded neonatal foreskins and PCR assessments. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were immortalized by infection with hTERT-pWZL-blast⑀ retrovirus and semRNA expression was analyzed for each sample in parallel wells to assess lection with blasticidin (Invitrogen) at population doubling 20. Tet-EF cells the integrity of the RNA. Primers and probes were obtained from Integrated were generated by retroviral transduction of pREV-TETOFF (Clontech). Fol-DNA Technologies as follows: p53for, 5Ј-GCCAAAGAAGAAACCACTGG lowing neomycin selection, a portion of the surviving population was infected ATG-3Ј; p53rev, 5Ј-TGAGTTCCAAGGCCTCATTCAG-3Ј; p53probe, 5Ј-FAMwith FLAG-EWS/FLI-pREV-TRE retrovirus and subjected to hygromycin se-ATTTCACCCTTCAGATCCGTGGGCGT-TAMRA-3Ј; p14ARFfor, 5Ј-TGATG lection in the presence of tetracycline. Negative control cells were prepared CTACTGAGGAGCCAGC-3Ј; p14ARFrev, 5Ј-ACCACCAGCGTGTCCAGGAA-3Ј; by introducing an empty pREV-TRE retroviral construct instead of the EWS/ p14ARFprobe, 5Ј-FAM-ACTCTCACCCGACCCGTGCACGACGCTGC-TA FLI-containing construct. Cells were maintained in 10%FCS in DMEM sup-MRA-3Ј; GAPDHfor, 5Ј-GAAGGTGAAGGTCGGAGT-3Ј, GAPDHrev, 5Ј-GAA plemented with 1 g/ml doxycycline or tetracycline, 300 g/ml G418, and GATGGTGATGGGATTTC-3Ј; and GAPDHprobe, 5Ј-VIC-CAAGCTTCCCGT TCTCAGCC-TAMRA-3Ј. 100 g/ml hygromycin.
Induction of EWS/FLI was accomplished by plating the cells in media containing 1 g/ml tetracycline the day before induction, washing the tetPulse-chase analysis of p53 EF cells three times with phosphate-buffered saline (PBS) on the day of Tet-EF cells were plated in 6 cm plates in the presence or absence of doxycycline 3 days prior to analysis. Cells were then preincubated for 1 hr induction, and refeeding with tetracycline-free growth media.
